Status:
RECRUITING
Writing Relaxing Beats in Adolescents Who Have Sickle Cell Disease
Lead Sponsor:
Mayo Clinic
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
11-18 years
Phase:
NA
Brief Summary
This research aims to see if songwriting can help reduce anxiety in adolescents with Sickle Cell Disease. The purpose of the study is to discover if participants find songwriting and playing their son...
Eligibility Criteria
Inclusion
- Adolescents aged 11-18 years of age at the time of enrollment and able to provide assent
- Diagnosed with any type of sickle cell disease
- Currently receiving care at pediatric center
- Able to read and write in English
Exclusion
- Care transitioned to adult facility
- Visual, hearing, or cognitive impairment which may impede the ability to complete the songwriting intervention or data collection measures
Key Trial Info
Start Date :
January 5 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07222475
Start Date
January 5 2026
End Date
July 31 2026
Last Update
December 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Division of Nursing
Rochester, Minnesota, United States, 55905